Minas Chrysopoulo MD, PRMA Plastic Surgery

07/29/2026

A rise in breast cancer among younger women changes what happens in my part of a patient's care, not just the oncologist's.

A recent UCSF study found invasive breast cancer climbing fast among Asian American women, more than 3% a year across nearly every group, and rising fastest in women under 50. More of these cancers are aggressive types. The researchers are honest that they don't yet know why.

More younger patients doesn't necessarily mean more mastectomies. Modern chemotherapy given before surgery is often shrinking tumors and opening up breast-conserving options. What it does mean is more women, earlier in life, facing real decisions: lumpectomy or mastectomy, reconstruction with implants or their own tissue, going flat, sensation, timing.

The rise is steepest in certain communities and in women under 50. A change this fast is exactly what a good care system can get ahead of. Screening aimed at who's really at risk, outreach in the right languages, and clear paths that carry these women to specialist care without losing them along the way.

https://medicalxpress.com/news/2026-07-breast-cancer-fast-asian-american.html



PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA

A new study led by UC San Francisco has found an alarming rise in invasive breast cancer among Asian American women over the last two decades.

07/22/2026

When a medical device gets recalled, it's easy to see it as paperwork between a company and the FDA. For the patient it was used on, it's much more personal.

A new study in JAMA Network Open looked at 903 AI-powered medical devices authorized by the FDA. Devices with no publicly reported clinical evidence behind them were more likely to end up recalled.

Here's what I want patients to take from this: you're allowed to ask questions about any device involved in your care. What's the evidence behind it? A good care team welcomes those questions.

Asking isn't second-guessing your doctors. It's part of good care.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2850190



PRMA Plastic Surgery - Center for Advanced Breast Reconstruction

This cohort study examines characteristics of artificial intelligence (AI)–enabled medical devices, including clinical study evidence, associated with US Food and Drug Administration (FDA) recall.

07/15/2026

"No shared records. No standard handoff. No common language." That's how two primary care physicians and an oncologist described cancer care coordination recently, and the specific gap they're naming is the handoff from oncology to primary care once active treatment ends.

That's the moment a patient's survivorship plan, their ongoing surveillance needs, and who's actually responsible for catching problems all move to a doctor who wasn't in the room for any of the decisions that got them there.

Breast reconstruction tends to show the same pattern. Follow-up runs on its own track, separate from oncology's surveillance, with no formal bridge between the two once the acute phase passes.

A standardized survivorship care plan handed to the P*P at the point of transition would close most of that gap on its own. Pair it with a single point of contact on the oncology side the P*P can actually reach, and a good part of this resolves itself.

At PRMA, our doctors close this gap well because they care, not because the system requires it. That's the part we still need to fix.

https://www.medscape.com/viewarticle/lost-translation-cancer-cares-coordination-problem-2026a1000mkw



PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA

No shared records. No standard handoff. No common language. Three physicians break down why cancer care coordination keeps failing.

06/24/2026

Patients are often told their new breast will likely be numb after a mastectomy and reconstruction. Most don't make the connection that numb means they won't feel their skin burning from a hot compress, or a scratch, or a graze from a sharp edge.

Neurotization doesn't restore the degree of feeling that Mother Nature provided before the mastectomy, and it doesn't typically come close to erogenous sensation. What it does deliver is meaningful sensory recovery, protective sensation to prevent skin injury, and being able to feel a hug or a touch. For most women, that's a significant difference in how they experience their body after reconstruction.

A systematic review just published in *Cancers* looked at 40 studies and confirmed that reconnecting sensory nerves during reconstruction leads to earlier, better, and more protective sensation. Non-neurotized flaps left 64% of patients with no return of protective sensation at all.

At PRMA we pioneered TruSense®, a technique that neurotizes DIEP flaps without cadaveric nerve grafts, because we believe feeling should be part of what holistic reconstruction delivers, not a bonus if it happens to return on its own. The evidence behind that belief keeps getting stronger.

Sensation is part of what reconstruction is for. That's the paradigm shift in thinking the field needs to embrace.

Learn more about TruSense®: https://prma-enhance.com/lymphedema-restorative-procedures/sensation-restoration

Read the full review: https://pmc.ncbi.nlm.nih.gov/articles/PMC13072177/



PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA Methodist Health System Baptist Breast Center

Breast sensation is often lost at the time of mastectomy and has a significant impact on a patient’s quality of life and survivorship. New approaches seek to restore sensation in the setting of breast reconstruction. This review summarizes the ...

06/03/2026

The standard post-surgical exercise advice for breast cancer patients has been: go easy, go slow, don't lift heavy. This study challenges that directly.

At the recent American Society of Breast Surgeons annual meeting in Seattle, researchers from Allegheny Health Network presented data on 197 breast cancer survivors who completed a three-month supervised resistance training program with dose escalation. The findings held regardless of whether patients had undergone mastectomy or axillary lymph node dissection. Strength, range of motion, and muscle mass improved to the same or greater levels than before surgery, in months, not years.

Dr. Colin Champ put it plainly: "We don't want to injure anyone, but to underdose someone is equally bad."

Some of the caution has real clinical basis. Lymphedema risk is real, though Champ noted those concerns around resistance training have been largely disproven. Many of these patients are also genuinely deconditioned after surgery, chemotherapy, radiation, and sometimes a year or more of accumulated treatment burden. The question isn't so much as to whether to be careful. It's whether what we've been recommending matches what patients can actually do and benefit from.

At the breast cancer tumor board level, we've seen tremendous patient benefit when oncorehab approaches are incorporated into multidisciplinary clinical pathways, both as prehab to prepare patients for surgery and as part of structured recovery afterward. When it's treated as a clinical priority from the start, not an afterthought, patients do better.

Appropriate resistance training improves every physical aspect that correlates with outcomes after cancer treatment. For those of us working with breast cancer survivors, it's worth revisiting what we're recommending and giving serious consideration to the role exercise oncology and oncorehab can play.

https://medicalxpress.com/news/2026-05-high-intensity-breast-cancer-surgery.html



PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA Methodist Healthcare System Baptist Breast Center The American Society of Breast Surgeons

After breast cancer surgery, many women are told to limit how much—and how soon—they exercise.

05/20/2026

Cancer survivorship is growing. That's genuinely great news. Survivorship with lymphedema is a different story.

For many breast cancer patients, lymphedema is a direct consequence of the treatment that saved their life. Chronic swelling, limited movement, recurrent infections, the daily burden of compression garments. Studies suggest it affects somewhere between 20% and 30% of those treated, depending on treatment type. For years, the main options were compression garments and massage. Helpful, but not a solution.

Microsurgical procedures can now treat and in some cases prevent lymphedema. LVA (Lymphaticovenous Anastomosis), VLNT (Vascularized Lymph Node Transfer), VOLT (Vascularized Omentum Lymph Node Transfer): procedures that redirect or rebuild the lymphatic system. They work. The problem is that most patients never learn these options exist, because only a handful of centers in the country have the expertise to do this work. PRMA is one of them.

Dr. Anton Fries leads our lymphedema program at PRMA. Patients come to us from all over the world because this work requires a level of microsurgical specialization that most centers simply don't offer.

If you or someone you know is living with lymphedema after cancer treatment and has been told compression is the only option, it may not be. A consultation is the right place to start.

Learn more about your lymphedema surgery options here: prma-enhance.com/post-mastectomy-care/lymphedema-treatment/



PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA Methodist Healthcare System Baptist Breast Center

PRMA offers advanced lymphedema treatment in San Antonio. Discover surgical options for relief and recovery after breast cancer and mastectomy.

05/13/2026

When a patient calls after a diagnosis, that first conversation matters more than most people realize. Whether she reaches someone immediately, whether she's matched to the right surgeon, whether her appointment actually leads to a surgical date — these details shape how her care unfolds from day one.

This piece on Luminai and Cleveland Clinic resonates with me because we're working through a very similar challenge at PRMA right now. Our intake process has to do a lot at once: connect immediately with patients who call or reach out online, match them to the right surgeon based on their preferences and their referring physician's relationship, account for each surgeon's service focus, and align the appointment with the next available surgical date.

That last piece is something most scheduling systems don't even try to solve. For a patient planning surgery, it's one of the most important parts of the whole process.

We're exploring AI to help optimize the entire intake workflow behind the scenes. Not just for efficiency's sake but to do better for our patients. By removing “mundane” repetitive administrative tasks that can be so time-consuming from their plates, our team can have more time for what they’re best at… being caring, compassionate humans. That’s the ultimate goal.



https://medcitynews.com/2026/04/luminai-cleveland-clinic/
PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Cleveland Clinic Advanced Reconstructive Surgery Alliance -ARSA

Luminai raised $38 million in Series B funding to scale its AI platform that automates healthcare administrative workflows. The company is working with Cleveland Clinic to expand the use of its system across high-volume processes, starting with referral management.

04/22/2026

When surgeons get better, patients benefit. That’s the whole point of events like the ARSA Summit 2026, hosted by our parent organization last week in Weehawken, NJ. Dr Merceron and I made the trip to proudly represent PRMA.

Physicians traveled from across the United States and from other countries to attend.

Two days of hands-on training, real case presentations, and deep clinical discussion across some of the most complex areas in reconstructive surgery: breast reconstruction after mastectomy, post-mastectomy pain, lymphedema, nerve repair, and robotic surgical techniques.

One thing from the cadaver lab is worth highlighting. Many of the procedures being taught and demonstrated were not developed elsewhere and imported into the training. They were created by ARSA surgeons. That means patients treated within our network have access to techniques that exist, in some cases, nowhere else.

We also celebrated our inaugural ARSA Awards, recognizing physicians who are building beyond their own practices. Dr. Sean Boutros for 16 years of sustained innovation in microsurgical breast reconstruction. Dr. Joseph Dayan for building a specialty program now reaching patients across multiple states. Dr. Ajul Shah for the remarkable way he invests in developing the next generation of surgeons.

These awards matter because they signal what we value as an organization: not just individual excellence, but the kind of work that raises the standard for everyone.

None of this happens without the support of our industry sponsors, who make the summit possible year after year. Their partnership allows us to bring this community together, invest in education, and keep pushing the standard of care forward. We are genuinely grateful.

For patients navigating complex reconstructive decisions, a physician-led network that trains together, innovates together, and holds each other to a higher standard is a difference that shows up in your care.

PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA

04/15/2026

Every woman in this article says the same thing. Nobody told them post-mastectomy pain syndrome was a realistic possibility. They signed forms. They technically consented. But they weren't prepared.

The numbers tell a different story than what some patients are hearing from their doctors. As one woman in the piece puts it, her doctors acted like it was so rare, like they were baffled. In reality, this is statistically predictable.

Between 25% and 40% of women who undergo mastectomy develop some degree of PMPS. For women under 50, cumulative prevalence reaches 65%. This is likely because younger women receive more aggressive treatment, have more sensitive nervous systems, and carry a higher psychosocial burden through recovery. On top of that, 10% of opioid-naive patients are still using opioids 90 days after mastectomy because the underlying pain was never properly addressed. These are often younger, higher-functioning women ending up on chronic opioids because nobody told them a surgical solution exists.

If you or someone you love is dealing with pain after mastectomy, please know: you are not imagining it, it is not rare, and there are options. Learn more here: https://prma-enhance.com/post-mastectomy-care/post-mastectomy-pain-syndrome

PRMA Plastic Surgery - Center for Advanced Breast Reconstruction Advanced Reconstructive Surgery Alliance -ARSA

Post-mastectomy pain syndrome, or PMPS, is estimated to afflict tens of thousands of U.S. women each year. It is not well understood.

04/08/2026

Where you live shouldn’t determine the care you receive. Unfortunately, as many of you know, it often does.

It’s exciting to see new technology making it possible for patients to connect with the right surgeon, no matter where they live. The greatest promise isn’t the technology itself, but what it could mean for access: getting the right care, at the right time, without geography being a barrier.

At PRMA, we see this every day. Patients travel to us from across the U.S. and around the world because some advanced reconstructive options simply aren’t available where they live. That’s not easy for patients or families, and it highlights an important opportunity: to bring that level of care closer to home.

At the same time, surgery is about much more than the operation itself. It involves careful planning, a skilled team, anesthesia support, and having the right systems in place to keep patients safe, especially if something unexpected happens.

That’s where outcomes truly matter.

The path forward is thoughtful and step-by-step. Start with the right cases, build strong, well-trained teams working together, and ensure safety and consistency every time. If done well, this kind of innovation could help many patients avoid long travel and get the care they need sooner, not just in breast reconstruction, but across many areas of medicine.

The opportunity is real, and very exciting. What matters most is that outcomes continue to match.

PRMA Plastic Surgery - Center for Advanced Breast Reconstruction

The milestone procedure went well, with patient Paul Buxton saying he felt "fantastic".